Innovative Eyewear (LUCY) Cash from Investing Activities (2021 - 2025)
Innovative Eyewear (LUCY) reported Cash from Investing Activities of $824870.0 for Q4 2025, up 1442.98% on a YoY basis from $53459.6 in Q4 2024, and up 5660.3% sequentially from -$14835.0 in Q3 2025.
Innovative Eyewear (LUCY) Cash from Investing Activities (2021 - 2025) Analysis & Trends
Innovative Eyewear (LUCY) has 5 years of Cash from Investing Activities data on file, last reported at $824870.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Investing Activities rose 1442.98% year-over-year to $824870.0; the trailing twelve-month figure through Dec 2025 stood at $4.5 million (up 186.71% YoY), and the FY2025 full-year result was $4.5 million, up 186.71% from the prior year.
- Cash from Investing Activities advanced to $824870.0 in Q4 2025, from -$14835.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $4.9 million in Q1 2025 to a low of -$5.0 million in Q3 2024.
- A 5-year average of -$65152.4 and a median of -$59547.5 in 2022 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities tumbled 13007.41% in 2023 and soared 5270.96% in 2025, its largest moves.
- Tracing LUCY's Cash from Investing Activities over 5 years: stood at -$31208.0 in 2021, then sank by 106.75% to -$64523.0 in 2022, then surged by 3215.05% to $2.0 million in 2023, then sank by 103.06% to -$61421.0 in 2024, then jumped by 1442.98% to $824870.0 in 2025.
- Business Quant data shows LUCY's Cash from Investing Activities at $824870.0 in Q4 2025, -$14835.0 in Q3 2025, and -$1.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 129.26 Bn | 124.05 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 46.23 Bn | 45.42 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 33.66 Bn | 32.00 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 33.07 Bn | 30.84 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 30.36 Bn | 28.70 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 24.00 Bn | 23.56 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.89 Bn | 14.33 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.96 Bn | 13.82 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 12.52 Bn | 10.51 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Innovative Eyewear | 2.98 Mn | -4.80 Mn | 114,746.00 | 824,870.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 824,870.00 |
| Dec 31, 2025 | 824,870.00 |
| Sep 30, 2025 | -14,835.00 |
| Sep 30, 2025 | -14,835.00 |
| Jun 30, 2025 | -1.27 Mn |
| Jun 30, 2025 | -1.27 Mn |
| Mar 31, 2025 | 4.94 Mn |
| Mar 31, 2025 | 4.94 Mn |
| Dec 31, 2024 | -61,421.00 |
| Dec 31, 2024 | -61,421.00 |
| Sep 30, 2024 | -4.99 Mn |
| Sep 30, 2024 | -4.99 Mn |
| Jun 30, 2024 | -18,273.00 |
| Jun 30, 2024 | -18,273.00 |
| Mar 31, 2024 | -95,538.00 |
| Mar 31, 2024 | -95,538.00 |
| Dec 31, 2023 | 2.01 Mn |
| Dec 31, 2023 | 2.01 Mn |
| Sep 30, 2023 | -93,417.00 |
| Sep 30, 2023 | -93,417.00 |